Innospec (IOSP) | Stock Overview & Key Data
Innospec Performance Comparison
Stock Range
Today's Range
Low: $81.91
High: $83.80
on July 29, 2025
52 Week Range
Low: $80.32
High: $133.53
on April 7, 2025
on July 31, 2024
All-Time High: $133.71 on May 6, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.1B
EPS
1.08
P/E Ratio (TTM)
76.28
Forward P/E
13.16
P/B Ratio
1.63
PEG Ratio
13.16
Div. Yield
1.97%
ROE
2.20%
Beta
1.031
Debt to Equity
3.51
Financial Highlights
Profitability
Gross Margin
28.38%
Operating Margin
9.76%
Profit Margin
1.51%
Returns and Earnings
Return on Assets (TTM)
0.81%
Return on Equity (TTM)
2.20%
EBITDA
$370.4M
Net Income (TTM)
$27.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$71.56
Quarterly Revenue Growth (YoY)
-11.90%
Quarterly Earnings Growth (YoY)
-20.80%
Dividend Information
Last 12-Month Dividend
$1.63
Current Dividend Yield
1.97%
3-Year Average Dividend Yield
0.70%
3-Year Average Annual Dividend
$1.48
3-Year Total Dividends
$4.45
Ex-Dividend Date
May 20, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Innospec IOSP | 2.06B Mid-cap | -3.17% | -2.43% | -8.73% | -28.63% | -23.77% | -32.44% | -13.85% | 3.87% |
| Linde plc LIN | 222.60B Mega-cap | -0.11% | 0.50% | 4.65% | 7.57% | 13.84% | 3.86% | 56.14% | 92.21% |
| Sherwin-Williams SHW | 84.80B Large-cap | -0.91% | -1.86% | -3.21% | -6.50% | 1.14% | -2.96% | 42.13% | 53.93% |
| Albemarle ALB | 9.85B Mid-cap | 8.65% | 38.69% | 45.05% | -5.68% | -1.75% | -9.76% | -65.72% | 1.55% |
| Eastman Chemical EMN | 8.86B Mid-cap | -4.14% | 1.53% | -0.58% | -18.23% | -14.37% | -22.25% | -20.32% | 3.75% |
| NewMarket NEU | 6.66B Mid-cap | -5.29% | -0.46% | 14.84% | 39.18% | 34.68% | 24.82% | 128.99% | 89.66% |
Ownership & Short Interest
Insider Ownership
1.26%
Institutional Ownership
99.77%
Shares Short
261K
Short Ratio
1.09
Short % of Shares Outstanding
1.47%
Average 10-Day Volume
176K
Average 90-Day Volume
218K
Innospec Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Innospec would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IOSP's 52-week high and low?
- In the last 52 weeks, Innospec reached a high of $133.53 (on July 31, 2024) and a low of $80.32 (on April 7, 2025).
- What is the market cap and P/E ratio for IOSP?
- Curious about Innospec's size and valuation? Its market capitalization stands at 2.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is 76.28, and the forward P/E (looking ahead) is 13.16.
- Does IOSP pay dividends? If so, what's the yield?
- Yes, Innospec is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.97%, and the company has paid an average of $1.48 per share annually over the past 3 years.
- Who are Innospec's main competitors or similar companies to consider before investing?
When looking at Innospec, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Linde plc
LIN222.60B Basic Materials Specialty Chemicals 3.86% 56.14% Sherwin-Williams
SHW84.80B Basic Materials Specialty Chemicals -2.96% 42.13% Albemarle
ALB9.85B Basic Materials Specialty Chemicals -9.76% -65.72% Eastman Chemical
EMN8.86B Basic Materials Specialty Chemicals -22.25% -20.32% NewMarket
NEU6.66B Basic Materials Specialty Chemicals 24.82% 128.99% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Innospec Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Innospec's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.20%, the Debt to Equity ratio from the most recent quarter is 3.51, and its Gross Profit Margin stands at 28.38%.
- What is the recent revenue and earnings growth for IOSP?
- Looking at Innospec's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -11.90%, and quarterly earnings saw a YoY growth of -20.80%.
- How much of IOSP stock is held by insiders and institutions?
- Wondering who owns Innospec stock? Company insiders (like executives and directors) hold about 1.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.